Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Indiana University Research and Technology Corporation currently has 6 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are distributed among 6 distinct examiners and 4 distinct art units, indicating a diverse range of active cases across different technical specialties. This distribution suggests a broad research and development focus, requiring the university to manage multiple examiner styles and art unit standards simultaneously.
The busiest examiner, MINCHELLA, ADAM ZACHARY, is handling 1 pending office action. Because each of the pending office actions is assigned to a different examiner, the workload is evenly spread, which prevents any single examiner from having an outsized influence on the overall portfolio. However, this also means that the university must tailor different prosecution strategies to meet the specific preferences of each examiner. With 4 distinct art units involved, the university's legal team must also navigate varying levels of scrutiny and different procedural norms within the Biotechnology & Pharmaceuticals sector.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (17%) |
| §101 + other | 1 (17%) |
| §112 only | 1 (17%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MINCHELLA, ADAM ZACHARY | 1 | 64.1% | +33.9% |
| BALAJ, ANTHONY MICHAEL | 1 | 30.6% | +30.6% |
| WRIGHT, ERIC BRANDON | 1 | — | — |
| MCMILLIAN, KARA RENITA | 1 | 30.7% | +37.9% |
| HA, JULIE | 1 | 75.7% | +44.0% |
| STAVROU, CONSTANTINA E | 1 | 43.7% | +36.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17119484 | DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS | STAVROU, CONSTANTINA E | 44d overdue |
| 18966692 | SYSTEM AND METHOD FOR DIAGNOSING SLEEP DISORDERS | MINCHELLA, ADAM ZACHARY | — |
| 18743003 | SYSTEMS AND METHODS FOR ACCESSING, COMBINING AND COLLABORATIVE FILTERING OF INFORMATION FROM MULTIPLE ELECTRONIC HEALTH RECORDS | BALAJ, ANTHONY MICHAEL | — |
| 18428855 | THERAPEUTIC TARGETING OF RECEPTOR TYROSINE KINASE INHIBITOR-INDUCED ANDROGEN RECEPTOR PHOSPHORYLATION IN CANCER | MCMILLIAN, KARA RENITA | — |
| 17925477 | PTH ANALOGS FOR THE TREATMENT OF HYPOPARATHYROIDISM | HA, JULIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17119484 | DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS | STAVROU, CONSTANTINA E | 44d overdue |
| 18966692 | SYSTEM AND METHOD FOR DIAGNOSING SLEEP DISORDERS | MINCHELLA, ADAM ZACHARY | — |
| 18743003 | SYSTEMS AND METHODS FOR ACCESSING, COMBINING AND COLLABORATIVE FILTERING OF INFORMATION FROM MULTIPLE ELECTRONIC HEALTH RECORDS | BALAJ, ANTHONY MICHAEL | — |
| 18428855 | THERAPEUTIC TARGETING OF RECEPTOR TYROSINE KINASE INHIBITOR-INDUCED ANDROGEN RECEPTOR PHOSPHORYLATION IN CANCER | MCMILLIAN, KARA RENITA | — |
| 17925477 | PTH ANALOGS FOR THE TREATMENT OF HYPOPARATHYROIDISM | HA, JULIE | — |
| Art Unit | Apps |
|---|---|
| 1632 | 2 |
| 3682 | 1 |
| 1623 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18966692 | SYSTEM AND METHOD FOR DIAGNOSING SLEEP DISORDERS | MINCHELLA, ADAM ZACHARY | — | §103§112 | Non-Final OA | — | Pending | Dec 03, 2024 |
| 18743003 | SYSTEMS AND METHODS FOR ACCESSING, COMBINING AND COLLABORATIVE FILTERING OF INFORMATION FROM MULTIPLE ELECTRONIC HEALTH RECORDS | BALAJ, ANTHONY MICHAEL | 3682 | §101 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18605786 | GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE TREM2 P.R47H AND METHODS OF USE THEREOF | WRIGHT, ERIC BRANDON | 1632 | §112 | Final Rejection | 27d | Pending | Mar 14, 2024 |
| 18428855 | THERAPEUTIC TARGETING OF RECEPTOR TYROSINE KINASE INHIBITOR-INDUCED ANDROGEN RECEPTOR PHOSPHORYLATION IN CANCER | MCMILLIAN, KARA RENITA | 1623 | §102§103 | Non-Final OA | — | Pending | Jan 31, 2024 |
| 17925477 | PTH ANALOGS FOR THE TREATMENT OF HYPOPARATHYROIDISM | HA, JULIE | 1654 | §103§112 | Non-Final OA | — | Pending | Nov 15, 2022 |
| 17119484 | DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS | STAVROU, CONSTANTINA E | 1632 | §101§102§103 | Non-Final OA | 44d overdue | Pending | Dec 11, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial